Morning Overview on MSN
A single daily pill just nearly doubled how long patients with advanced pancreatic cancer lived — full phase 3 daraxonrasib data drops live at ASCO today
Pancreatic cancer kills roughly 80% of patients within a year of diagnosis. For those whose tumors have already spread and ...
Capricor Therapeutics recently presented data from its Phase 3 HOPE-3 trial of Deramiocel for Duchenne muscular dystrophy at the 2026 American Academy of Neurology meeting, highlighting statistically ...
Zasocitinib showed superiority over placebo in phase 3 trials, achieving rapid and sustained skin clearance in plaque psoriasis. The trials demonstrated a favorable safety profile, with common adverse ...
Key Points Interested in Eyepoint Pharmaceuticals, Inc.? Here are five stocks we like better. EyePoint Pharmaceuticals said ...
Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results